Overview
Anti TNF α Improves Endothelial Dysfunction in IBD Patients
Status:
Unknown status
Unknown status
Trial end date:
2018-06-01
2018-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Study hypothesis - this study will assess the presence of endothelial dysfunction in patients with Crohn's disease before and after 12 weeks treatment of anti TNF α.Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Carmel Medical CenterTreatments:
Adalimumab
Infliximab
Criteria
Inclusion Criteria:- Non smoker
- No history of IHD or other known risk factors for IHD
Exclusion Criteria:
- Patients who had been treated with anti TNF α 4 weeks before the study
- As well as those who received corticosteroids within 1 week before the study.
- DM, IHD, CRF, SMOKER